feed,title,long_url,short_url
SeekingAlpha,Immunic surges ~20% as IMU-838 shows promise in ulcerative colitis trial,https://seekingalpha.com/news/3954616,
SeekingAlpha,"TransAct Technologies appoints John Dillon as interim CEO, reiterates guidance",https://seekingalpha.com/news/3954618,
SeekingAlpha,Momentus names Eric Williams CFO,https://seekingalpha.com/news/3954617,
